SERPINB3 and metabolic dysfunction-associated steatohepatitis: The profibrogenic action of SerpinB3 has been outlined using transgenic mice manipulated to overexpress SerpinB3 in hepatocytes and submitted to two distinct protocols for induction of liver fibrosis, namely, chronic CCl4 treatment and the NASH-related MCD diet.